All Stories

  1. Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective

    Article • Journal of Medical Economics, April 2018, Taylor & Francis

    Professor Stephen John Palmer

  2. Unifying Research and Reimbursement Decisions: Case Studies Demonstrating the Sequence of Assessment and Judgments Required

    Article • Value in Health, September 2015, Elsevier

    Professor Stephen John Palmer

  3. The CHD challenge: Comparing four cost-effectiveness models

    Article • Value in Health, January 2011, Elsevier

    Professor Stephen John Palmer